Apexigen, Inc.
APGNDelisted Aug 23, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001814140
Apexigen, Inc. was delisted on Aug 23, 2023; its insiders filed their last Form 4 on Aug 25, 2023; 17 institutions reported holding it in 13F filings for Q2 2023, worth $1.37M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Apexigen, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 20 | 17 | −3 |
| Shares | 3.37M | 3.19M | −176.9K (−5.3%) |
| Value | $1.64M | $1.37M | −$273.3K (−16.6%) |
New holders (1)
Institutions that held Apexigen, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JBF Capital, Inc. | 9,130 | $3.92K | 0.00% |
Sold out (4)
Institutions that held Apexigen, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| CVI Holdings, LLC | 150,000 | $75.0K |
| Millennium Management LLC | 21,771 | $11.0K |
| Susquehanna International Group, LLP | 15,546 | $7.77K |
| UBS Group AG | 4,376 | $2.13K |